In this issue:

Our final 2010 issue continues using a crystal ball. Our previous issue asked authors to look at the EU competition policy world of 2025. For this issue, we posed the same challenge to U.S. authors. Some chose very specific topics (tying, reverse payments) while others are broader in scope—but all have the courage of their convictions. And to wrap up the year in Asia, we’ve included an article analyzing the first year of India’s competition enforcement. Happy New Year, everyone!

U.S. Antitrust in 2025

Kent Bernard, Dec 16, 2010

U.S. Antitrust 2025: How Have We Handled The Bulletproof Cartels?

Have we created what are, in effect, government-sanctioned, bulletproof, cartels? Kent Bernard (Fordham Law School)

Dec 16, 2010

2025: Reverse-Payment Settlements Unleashed

The year is 2025. For the past two decades, brand-name drug companies have settled infringement lawsuits with generic firms by paying them to drop their patent challenges. Michael Carrier (Rutgers Univ. School of Law—Camden)

Christopher R. Leslie, Dec 16, 2010

The End of Per Se Illegal Tying

By the year 2025, the breadth of the per se rule will narrow yet again and federal courts will evaluate tying arrangements under the rule of reason. Christopher Leslie (Univ. of California Irvine School of Law)

Daniel Sokol, Dec 16, 2010

Antitrust in 2025: Cartels, Agency Effectiveness and a Return to Back to the Future?

It is increasingly apparent that academics an


Please sign in or join us
to access premium content!